Walk-in for QA, Prodn, QC, Process Engg on 28/05/2016 at ankleshwar


Walk-in for Quality Assurance , Production , Quality Control, Solvent Recovery Plant, Engineering ,  Process Engineering on 28th May 2016 at Ankleshwar

Here is a chance to join Zydus at our API Manufacturing located at Ankleshwar as.

Key Responsibilities are mentioned as below:

QUALITY ASSURANCE : Sr.Executive / Executive : M.Sc./ B.Sc Chemistry with 3 – 8 year , must be familiar with cGMP requirements, Data Integrity, Document Cell, Batch release process, Trending APR shop floor Operation in API / Bulk Drug

a) Data Integrity – Responsible to review of HPLC and GC , QC Sop Compliances, Investigation activities , OOS and OOT and quality control instruments.

b) Document Cell -Review of documents before DMF submissions, distribution / Issuance of BMRs, Master Formulae, SOPs and Formats to the respective departments and controlling all master documents.

c) Batch Release
– Knowledge of ICH guidelines and should review of BMRs and Validation documents and to give usage decision and dispatch of all APIs and salable intermediates in LIMS and SAP.

d) Technology transfer documents – Review R&D process & TTD, evaluation of CPP & CQA and comparison with batch record , review of master batch record also review of specification and

STP of API, Intermediate, RM, In-process.

e) Trending and APR – Knowledge of Market complaint, Deviation, Incident, Change control for trending of Systems, Review of Master SOPs, BMRs, PCRs, validation Protocols and reports and Annual Review reports.

Sr.Executive / Executive
: Diploma /B.E / B.TECH (chemical) M.Sc./ B.Sc. (Chemistry) with 4 to 7 years of experience and relevant exposure in API / Bulk Drug Manufacturing. Should also have knowledge of GMP documentation. Must be familiar with cGMP requirements.

QUALITY CONTROL : Sr.Executive / Executive : M.Sc /B.Sc (Chemistry) with 3 – 8 years of hands on experience and relevant exposure in handling instruments like HPLC, GC, UV , wet lab and chemical analysis of Raw Material . Must be familiar with cGMP requirements. Shop floor Operation in API / Bulk Drug Manufacturing.

Process Engineering
: Executive / Sr.Executive : B.E / B.TECH (chemical) with 3 to 6 years of experience and relevant exposure in API / Bulk Drug Manufacturing. Design of equipment, piping & facility. Solvent recovery. Heat & Mass balance. Capacity debottlenecking.

ENGINEEERING SERVICES : Sr.Executive / Executive : Diploma / B.E / B.TECH (Mechanical / Instrument / Electrical / Utility) with 2 to 8 years of experience and relevant exposure HVAC validations and qualifications , preventive maintenance of equipments in API / Bulk Drug Manufacturing.

SOLVENT RECOVERY PLANT : Executive / Sr.Executive : M.Sc./ B.Sc (Chemistry) , Diploma / B.E/ B.Tech (Chemical) with 2-7 years , must be familiar with Solvent recovery plant handling, Distillation of different type of solvents, solvent handlling,documetation related to c GMP ( BMR, change control, deviation, incidents , CAPA etc.), safety related to all SRP activity, knowledge of PLC system, SAP system.

Investigation Positions for Production / QC / Process engineering / Process development : Sr.Executive / Executive
Should have knowledge of investigation tools and technics. , Flow chart, Parato chart, Fishbone tech., Brain storming, 5 Why tech
Should be well versed with statistical analysis technics and data evaluation, ANOVA, Regression, Correlation, Minitab software.
Should be competent in Quality Risk Assessment technics, FMEA, Fault tree analysis.
Should have through knowledge of pharmaceutical manufacturing processes, unit operation and unit processes, Mixing, Blending, Type of reactor and agitators etc.
Should have experience in handling of failure investigations i.e OOS, OOT, market complain, deviations.
Should have experience / knowledge of working principles of quality control instruments, HPLC, GC, XRD etc.
Should have handled Phase-I investigations.
Should be conversant for utilization of Minitab software and Microsoft excel for data evaluation.
Should have knowledge of report writing, technical writing and presentation skill.
Should have knowledge of relevant regulatory guidelines, ICH-Q7, ICH-Q9,
USFDA OOS investigation etc.

Interested candidate may Walk-In for Interview along with their CVs and relevant documents at

      Interested candidate may Walk-In for Interview along with their CVs and relevant documents at

Date: 28th May 2016 (Saturday)

Time: 09:30 AM to 05:00 PM

Venue: VITS Shalimar
Valia Road,
Near G.I.D.C. Reservoir,
Dist :Bharuch,

Contact No of HR representative: 02646-660408 / 660507

Candidates having experience of working in regulatory approved plants and possesses sound knowledge of documentation, cGMP and SAP will be preferred.

Those who are unable to attend the Personal Interview may send their resume through e-mail at [email protected]

Please mention the position applying for on the top of envelope or subject in case of e-mail.

Preference will be given to candidates having API – Pharmaceutical Industries experience.

Company Profile:

Cadila Healthcare Limited – Akleshwar

Zydus Cadila is a fully integrated, global healthcare provider, with strengths all along the pharmaceutical value chain. With a core competence in the field of healthcare, Zydus Cadila provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products. From a turnover of Rs. 250 crores in 1995, the group posted revenues of over Rs. 8600 crores in FY15. The group had posted a turnover of Rs. 4600 crores in FY 11, making it a billion dollar company. Recently, the group launched Exemptia, the world’s first biosimilar for Adalimumab, the largest selling therapy worldwide for inflammatory arthritis.

Zydus is also the only Indian pharma company to launch its own patented NCE – Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia. The Zydus group was one amongst the top five companies worldwide at the FT ArcelorMittal Boldness in Business Awards 2014 in the Developing Markets category and was declared as the ‘Emerging Company of the Year’ by the Economic Times Awards for Corporate Excellence 2010. The group aims to be a leading global healthcare provider with a robust product pipeline and aspires to post revenues of Rs. 10000 crore by 2015-16 and be a research-based pharmaceutical company by 2020.


Please enter your comment!
Please enter your name here